Pricing Log in Create free account
Saturday 17 October 2026 Export LH’s income statement to Excel — free account

Labcorp Holdings Inc.

LH Healthcare Diagnostics & Research

Labcorp Holdings Inc.’s revenue for fiscal 2025 (year ended December 2025) was $14.0 billion, up 7.25% from fiscal 2024. In the quarter to June 2026, revenue grew 5.78%, EPS grew 28.4%, free cash flow fell 42.0% and total debt rose 15.1%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for five consecutive years, revenue growth for three.

318.66 6.41 −1.97%
Market cap
$26.4B
P/E
26.2×
Fwd P/E
19.0×
Dividend yield
0.90%
F-score
8/9
Altman Z
3.02
Beneish M
−2.55
Dividend safety
74/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Labcorp Holdings Inc. (LH) Price to free cash flow

Alert me on Price to free cash flow

As of 16 October 2026, Labcorp Holdings Inc. (LH) trades at a price to free cash flow of 25.2×. Over the past ten years it has ranged from 7.7× (April 2021) to 34.3× (April 2024); the current reading is higher than 89% of that period. That is below the Diagnostics & Research industry median of 35.8× and above the Healthcare sector median of 20.2×.

Price to free cash flow, daily

Embed this chart

Annual newest first

Period Price to free cash flow Change
FY2025 19.4× (3.22%)
FY2024 20.0× (27.11%)
FY2023 27.5× 125.45%
FY2022 12.2× 29.59%
FY2021 9.4× (0.79%)
FY2020 9.5× (30.00%)
FY2019 13.6× 19.84%
FY2018 11.3× (5.87%)
FY2017 12.0× 0.34%
FY2016 12.0× (17.01%)

Quarterly newest first

Period Price to free cash flow Change
Jun 2026 22.2× 27.27%
Mar 2026 17.4× (10.26%)
Dec 2025 19.4× 1.47%
Sep 2025 19.1× (1.50%)
42 more quarters

Against its own ten years

Low 7.7× High 34.3×
Ten-year median 13.7×
Current reading's percentile 89

Price to free cash flow against peers

Company Price to free cash flow
GH Guardant Health, Inc. compare n/m
DGX Quest Diagnostics Incorporated compare 19.3×
MEDP Medpace Holdings, Inc. compare 24.7×
LH Labcorp Holdings Inc. 25.2×
RVTY Revvity Inc. compare 30.1×
IDXX IDEXX Laboratories, Inc. compare 35.8×
MTD Mettler-Toledo International, Inc. compare 37.8×
ILMN Illumina, Inc. compare 43.2×
WAT Waters Corporation compare 117×
Diagnostics & Research industry median 35.8×
Healthcare sector median 20.2×
Market median 14.2×

What Price to free cash flow is

Price to Free Cash Flow Ratio shows how much investors pay for each dollar of cash a company generates after its capital spending.

Stock Price ÷ ((Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM)) ÷ (Shares (Basic, Weighted) (latest quarter)))

The full definition of Price to free cash flow →

More on LH